VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes [Elektronski vir] : a case report
    Stojkovska, Anisija ; Rus Prelog, Polona, psihiatrinja ; Kokalj Palandačić, Anja, medicina
    Semaglutide is a glucagon-like peptide-1 receptor agonist used in the treatment of type 2 diabetes mellitus and management of obesity. Associations of glucagon-like peptide-1 receptor agonist use ... with psychiatric adverse events and suicidal behavior have been reported. A man in his late 70s with type 2 diabetes and no history of psychiatric illness or cognitive deficits was admitted to our clinic after his first suicide attempt involving the impulsive ingestion of brush cleaner liquid. A month before his presentation, he reported restlessness and depressive mood without any apparent trigger. This period was consistent with the time of semaglutide introduction. His psychiatric symptoms improved after semaglutide discontinuation. This case report highlights the importance of regular monitoring of depression and anxiety symptoms and the possibility of suicidal ideation in individuals with type 2 diabetes treated with semaglutide. This may enable early detection and prevention of serious psychiatric adverse events.
    Vir: JIMR on-line [Elektronski vir]. - ISSN 1473-2300 (Vol. 53, iss. 6, 2025, str. 1-7)
    Vrsta gradiva - e-članek ; neleposlovje za odrasle
    Leto - 2025
    Jezik - angleški
    COBISS.SI-ID - 244930307

    Povezava(-e):

    https://journals.sagepub.com/doi/10.1177/03000605251349393
    DOI

Vnos na polico